Klaria Pharma Holding AB Summons Extraordinary General Meeting

Klaria Pharma Holding AB (publ) has formally invited its shareholders to an extraordinary general meeting scheduled for October 5, 2026. The meeting will commence at 10:00 a.m. at the law firm Glimstedt's office located at Sturegatan 46 in Stockholm.

Shareholders intending to participate must meet specific registration requirements. They need to be recorded in the share register maintained by Euroclear Sweden AB as of September 25, 2026. Furthermore, notification of attendance must be provided to the company no later than September 29, 2026.

Attendance notifications should be sent by post to Klaria Pharma Holding AB, Virdings Allé 2, 754 50 Uppsala. While the specific agenda items have not been detailed in the initial summons, extraordinary general meetings are typically convened to discuss and resolve on significant corporate matters.

The call for this meeting aligns with corporate governance practices, providing shareholders an opportunity to engage in the decision-making process. Further details regarding the meeting's proceedings and any associated documentation are expected to be made available according to regulatory guidelines.